Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
2.990
-0.140 (-4.47%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $277.16 million as of August 28, 2026. Its market cap has decreased by -65.85% in one year.
Market Cap
277.16M
Enterprise Value
158.84M
1-Year Change
-65.85%
Ranking
Category
Stock Price
$2.99
ChartMarket Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has decreased from $284.60M to $277.16M, a decrease of -2.61%. That is a compound annual growth rate of -0.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 277.10M | -12.89% |
| Dec 31, 2025 | 318.10M | -65.08% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 304.34M |
| Bicycle Therapeutics | 303.07M |
| Cartesian Therapeutics | 301.65M |
| Turn Therapeutics | 301.16M |
| Fulcrum Therapeutics | 293.74M |
| Lineage Cell Therapeutics | 293.37M |
| ALX Oncology Holdings | 283.47M |
| Surrozen | 282.20M |